Manuela Poretti-Rabaglio
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 11, 2023
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
Journal: JAMA
Published: May 24, 2022
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.
Journal: JNCI cancer spectrum
Published: April 14, 2021
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
Journal: NPJ breast cancer
Published: December 21, 2020
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 17, 2019
Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 28, 2018
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial.
Journal: The Lancet. Oncology
Published: August 15, 2018
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Journal: The New England journal of medicine
Published: June 05, 2018
A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 12, 2017
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: July 20, 2017
Adjuvant ovarian suppression in premenopausal breast cancer.
Journal: The New England journal of medicine
Published: December 16, 2014
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Journal: The New England journal of medicine
Published: June 03, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026